Has Arshia Soleimani, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,042 in general payments to Arshia Soleimani, MD across 196 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arshia Soleimani, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arshia Soleimani, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arshia Soleimani, MD

Hospitalist · Glen Burnie, MDNPI 1548689458

Payments from drug & device makers

$5,042in general payments, 2019–2025

Across 196 payments — averaging $25.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$391
E.r. Squibb & Sons, L.L.C.$344
Daiichi Sankyo Inc.$310
Novartis$308
Pfizer$287
Merck$281
plus $3K from 44 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead(2 entities)	16	$391
E.r. Squibb & Sons, L.L.C.	14	$344
Daiichi Sankyo Inc.	6	$310
Novartis	13	$308
Pfizer	12	$287
Merck	11	$281
AVEO Pharmaceuticals, Inc.	4	$281
Takeda Pharmaceuticals U.S.A., Inc.	7	$218
AstraZeneca(2 entities)	8	$190
Genentech USA, Inc.	7	$161
Lilly USA, LLC	5	$150
GSK	6	$149
Johnson & Johnson	7	$148
Mirati Therapeutics, Inc.	6	$136
Amgen	6	$126
Regeneron Healthcare Solutions, Inc.	6	$118
Eisai Inc.	4	$94
Seagen Inc.	4	$87
Pharmaessentia USA Corporation	3	$87
Bristol Myers Squibb	4	$85
Taiho Oncology, Inc.	3	$74
Sobi, Inc	4	$74
Astellas Pharma US Inc	3	$63
Array Biopharma Inc	3	$62
AbbVie	2	$54
Exelixis Inc.	2	$54
Rigel Pharmaceuticals, Inc.	2	$54
Sanofi	2	$47
Sumitomo Pharma America, Inc.	2	$47
Jazz Pharmaceuticals Inc.	1	$39
Morphosys, US Inc.	2	$39
Avyxa Pharma, LLC	1	$35
Beone Medicines USA, Inc.	1	$35
Deciphera Pharmaceuticals Inc.	2	$34
Puma Biotechnology, Inc.	2	$33
Genmab U.S., Inc.	1	$33
Syndax Pharmaceuticals, Inc.	1	$32
Pharmacyclics LLC, An Abbvie Company	1	$29
Organon	1	$29
Celltrion USA Inc.	1	$26
EMD Serono, Inc.	1	$26
Myovant Sciences Inc.	1	$22
EUSA Pharma (US) LLC	1	$22
Amneal Pharmaceuticals LLC	1	$22
Kyowa Kirin, Inc.	1	$21
Global Blood Therapeutics, Inc.	1	$20
Acrotech Biopharma Inc.	1	$18
Alnylam Pharmaceuticals Inc.	1	$17
ADC Therapeutics America, Inc.	1	$14
Medtronic	1	$14

How this compares

$5,042 in reported general payments places this provider in the 95th percentile of 414 hospitalist providers in Maryland.

See all hospitalist providers in Maryland →

Medicare billing

Part B allowed, 2024

$4,116,060

Medicare patients

444

Services billed

170,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in Glen Burnie

Brittany ShepherdBethesda$337K
Michael GreenBaltimore$242K
Francoise MarvelBaltimore$171K
Sadhasivam SithanandamTakoma Park$111K
Eric RitterBaltimore$94K
Anne FriedlandBaltimore$91K
Jung-Min LeeRockville$80K
Sarojini QasbaBethesda$53K
Anweshan SamantaBaltimore$24K
Andrew DemidowichBethesda$22K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →